Biota to Acquire the Antibacterial Assets of MaxThera

News   Nov 13, 2009

 
Biota to Acquire the Antibacterial Assets of MaxThera
 
 
 

RELATED ARTICLES

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News

Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..

READ MORE

Engineering the Gut Microbiome with 'Good' Bacteria May Help Treat Crohn's Disease

News

Researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. Replacement of the offending bacteria with "good" bacteria may offer an effective treatment approach.

READ MORE

BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences Products

News

BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE